Ethics and statistics in randomized clinical trials. With comments and a rejoinder by the author

DOI10.1214/SS/1177011934MaRDI QIDQ1596041zbMATH OpenOpenAlexWikidataFDO

Authors Richard M. Royall

Publication date 7 February 2001

Published in Statistical Science (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1214/ss/1177011934

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cited in

(12)

• Clinician preferences and the estimation of causal treatment differences. (With comments)
• Analyzing longitudinal count data from adaptive clinical trials: a weighted generalized quasi-likelihood approach
• Some topics of current interest in clinical trials
• Sequential procedures for comparing several medical treatments
• Social surveys and social science
• A class of adaptive designs
• A General Multi-Treatment Adaptive Design for Multivariate Responses
• Adaptive designs for binary treatment responses in phase III clinical trials: controversies and progress
• Ethics, data-dependent designs, and the strategy of clinical trials: time to start learning-as-we-go?
• Ethical issues in oncology biostatistics
• Comment: is response-adaptive randomization a ``good thing or not in clinical trials? Why we cannot take sides
• Information-theoretic criteria for optimizing designs of individually randomized stepped-wedge clinical trials

This page was built for publication: Ethics and statistics in randomized clinical trials. With comments and a rejoinder by the author

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1596041)